# EDGAR Filing Document

**Accession Number:** 0001679628
**File Stem:** 0001493152-25-026828
**Filing Date:** 2025-12
**Character Count:** 2424
**Document Hash:** e3ab8227bd34918a55492dc6a96a06cb
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001493152-25-026828.hdr.sgml**: 20260331

**ACCESSION NUMBER**: 0001493152-25-026828

**CONFORMED SUBMISSION TYPE**: CORRESP

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20251209

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** JUPITER NEUROSCIENCES, INC.
- **CENTRAL INDEX KEY:** 0001679628
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 474828381
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** CORRESP

**BUSINESS ADDRESS:**
- **STREET 1:** 1001 NORTH US HWY 1
- **STREET 2:** SUITE 504
- **CITY:** JUPITER
- **STATE:** FL
- **ZIP:** 33477
- **BUSINESS PHONE:** (561) 406-6154

**MAIL ADDRESS:**
- **STREET 1:** 1001 NORTH US HWY 1
- **STREET 2:** SUITE 504
- **CITY:** JUPITER
- **STATE:** FL
- **ZIP:** 33477

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Jupiter Orphan Therapeutics, Inc.
- **DATE OF NAME CHANGE:** 20160713

**Jupiter Neurosciences, Inc.**

**1001 North US HWY 1, Suite 504**

**Jupiter, Florida 33477**

December 9, 2025

**<u>VIA EDGAR</u>**

United States Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, DC 20549

---

| | |
|:---|:---|
| **Re:** | **Jupiter Neurosciences, Inc.** |
|  | **Registration Statement on Form S-1 (File No. 333-291832)** |

---

Ladies and Gentlemen:

Pursuant to Rule 461 under the Securities Act of 1933 and on behalf of Jupiter Neurosciences, Inc. (the "Company"), the undersigned hereby requests that the Company's Registration Statement on Form S-1 (File No. 333-291832) filed with the U.S. Securities and Exchange Commission on November 26, 2025 (the "Registration Statement"), be accelerated so that the Registration Statement will become effective on December 11, 2025, at 5:30 p.m., Eastern Standard Time, or as soon as practicable thereafter.

Please contact Katherine E. Geddes (kgeddes@reedsmith.com/telephone: (469) 680-4200) of Reed Smith LLP with any questions and please notify her when this request for acceleration has been granted.

---

| | |
|:---|:---|
| Very truly yours, | Very truly yours, |
| JUPITER NEUROSCIENCES, INC. | JUPITER NEUROSCIENCES, INC. |
| By: | */s/ Saleem Elmasri* |
|  | Saleem Elmasri |
|  | Chief Financial Officer and Secretary |

---

cc:

Katherine E. Geddes, Esq., Reed Smith LLP